Recenzija, Prikaz slučaja
APA 6th Edition
Béné, R., Antić, S., Budišić, M., Lisak, M., Trkanjec, Z., Demarin, V. i Podobnik-Šarkanji, S. (2009). Parkinson's disease. Acta clinica Croatica, 48 (3), 377-379. Preuzeto s https://hrcak.srce.hr/45288
MLA 8th Edition
Béné, Raphael, et al. "Parkinson's disease." Acta clinica Croatica, vol. 48, br. 3, 2009, str. 377-379. https://hrcak.srce.hr/45288. Citirano 03.07.2022.
Chicago 17th Edition
Béné, Raphael, Sonja Antić, Mislav Budišić, Marijana Lisak, Zlatko Trkanjec, Vida Demarin i Slava Podobnik-Šarkanji. "Parkinson's disease." Acta clinica Croatica 48, br. 3 (2009): 377-379. https://hrcak.srce.hr/45288
Béné, R., et al. (2009). 'Parkinson's disease', Acta clinica Croatica, 48(3), str. 377-379. Preuzeto s: https://hrcak.srce.hr/45288 (Datum pristupa: 03.07.2022.)
Béné R, Antić S, Budišić M, Lisak M, Trkanjec Z, Demarin V i sur. Parkinson's disease. Acta clinica Croatica [Internet]. 2009 [pristupljeno 03.07.2022.];48(3):377-379. Dostupno na: https://hrcak.srce.hr/45288
R. Béné, et al., "Parkinson's disease", Acta clinica Croatica, vol.48, br. 3, str. 377-379, 2009. [Online]. Dostupno na: https://hrcak.srce.hr/45288. [Citirano: 03.07.2022.]
Parkinson's disease is one of the most common neurodegenerative diseases caused by degeneration of dopaminergic neurons in substantia nigra. The neuropathologic hallmark of Parkinson's disease is the presence of Lewy bodies composed mostly of alpha-synuclein and ubiquitin. It is believed that the occurrence of Parkinson's disease is due to a combination of genetic and environmental factors, but the exact mechanism of Parkinson's disease development is not fully elucidated. The most characteristic motor symptoms for Parkinson's disease include bradykinesia, rigidity, resting tremor and postural instability, while many patients also have non-motor signs and symptoms. The key therapeutic agent in the treatment of Parkinson's disease is L-dopa, and the others are dopaminergic agents, monoamine oxidase-B (MAO-B) inhibitors, catechol-O-methyl transferase (COMT) inhibitors, amantadine and anticholinergic agents.
Posjeta: 6.771 *